Received May 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 47N3Y | IM / LA |
The following day she developed large local swelling at injection site with extreme skin sensitivity. This was followed by severe fatigue and brain fog which have persisted and remain present until today (5/20/2025)
none
NASH, obesity, depression, incontinence
Mirabegron, doxepin, multivitamin
oxycodone
N/a